Physician profile
Daniel Pinkhas
NPI 1518351485
$56,459.99
in general payments reported to CMS, 2019-2025
18 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2021: $11K · 2022: $34K · 2023: $8,427 · 2024: $1,455 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,249 · Travel and Lodging: $4,505 · Education: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,248.89 |
| Travel and Lodging | $4,505.05 |
| Education | $564.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38,941.30 | 2021-2024 | Micra, Aurora Ev-Icd Mri Surescan, Arctic Front Advance |
| Boston Scientific Corporation | $9,595.14 | 2021-2025 | Watchman Access System, Watchman, Watchman Flx |
| Abbott Laboratories | $4,282.60 | 2021-2025 | Ensite Precision, Ensite, Advisor |
| Medtronic Vascular, INC. | $961.65 | 2019 | |
| Medical Device Business Services, INC. | $930.73 | 2022-2023 | Carto 3 |
| Biosense Webster, INC. | $620.83 | 2022-2025 | Carto 3 |
| Cardiva Medical, INC. | $296.22 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $168.48 | 2022 | |
| Pfizer INC. | $140.57 | 2019-2024 | |
| Amgen INC. | $129.41 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.41 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $108.12 | 2024-2025 | Assure Wcd |
| Philips North America LLC | $44.66 | 2024-2025 | Mcot, (Ck7) Extended Holter, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $33.07 | 2019-2023 | |
| Itamar Medical INC | $29.23 | 2025 | Watchpatone |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.06 | 2023 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $21.79 | 2024 | Farxiga |
| Baxter Healthcare | $16.72 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pinkhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.